Potential treatment strategy for the rare osimertinib resistant EGFR L718Q mutation
J Thorac Dis
.
2022 Mar;14(3):599-601.
doi: 10.21037/jtd-22-100.
Authors
Akikazu Kawase
1
,
Yuichi Saito
2
Affiliations
1
First Department of Surgery, Hamamatsu University School of Medicine, Shizuoka, Japan.
2
Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
PMID:
35399244
PMCID:
PMC8987816
DOI:
10.21037/jtd-22-100
No abstract available
Publication types
Editorial
Comment